These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9114434)

  • 1. Induction of gamma-glutamyl transpeptidase mRNA by platinum complexes in a human ovarian carcinoma cell line.
    el-akawi Z; Zdanowicz J; Creaven PJ; Abu-hadid M; Perez R; Pendyala L
    Oncol Res; 1996; 8(10-11):415-23. PubMed ID: 9114434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered glutathione metabolism in oxaliplatin resistant ovarian carcinoma cells.
    el-akawi Z; Abu-hadid M; Perez R; Glavy J; Zdanowicz J; Creaven PJ; Pendyala L
    Cancer Lett; 1996 Jul; 105(1):5-14. PubMed ID: 8689632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines.
    Yao KS; Godwin AK; Johnson SW; Ozols RF; O'Dwyer PJ; Hamilton TC
    Cancer Res; 1995 Oct; 55(19):4367-74. PubMed ID: 7671249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment.
    Yao K; Godwin AK; Ozols RF; Hamilton TC; O'Dwyer PJ
    Cancer Res; 1993 Aug; 53(16):3662-6. PubMed ID: 8101766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by 5-fluorouracil of ERCC1 and gamma-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell line.
    Fujishima H; Nakano S; Masumoto N; Esaki T; Tatsumoto T; Kondo T; Niho Y
    Oncol Res; 1997; 9(4):167-72. PubMed ID: 9268987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
    Tew KD; Monks A; Barone L; Rosser D; Akerman G; Montali JA; Wheatley JB; Schmidt DE
    Mol Pharmacol; 1996 Jul; 50(1):149-59. PubMed ID: 8700107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-glutamylcysteine synthetase gene overexpression results in increased activity of the ATP-dependent glutathione S-conjugate export pump and cisplatin resistance.
    Kurokawa H; Ishida T; Nishio K; Arioka H; Sata M; Fukumoto H; Miura M; Saijo N
    Biochem Biophys Res Commun; 1995 Nov; 216(1):258-64. PubMed ID: 7488097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells.
    Goto S; Yoshida K; Morikawa T; Urata Y; Suzuki K; Kondo T
    Cancer Res; 1995 Oct; 55(19):4297-301. PubMed ID: 7671239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum drug effects on the expression of genes in the polyamine pathway: time-course and concentration-effect analysis based on Affymetrix gene expression profiling of A2780 ovarian carcinoma cells.
    Varma R; Hector S; Greco WR; Clark K; Hawthorn L; Porter C; Pendyala L
    Cancer Chemother Pharmacol; 2007 May; 59(6):711-23. PubMed ID: 17021820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional up-regulation of gamma-glutamylcysteine synthetase gene expression in melphalan-resistant human prostate carcinoma cells.
    Mulcahy RT; Untawale S; Gipp JJ
    Mol Pharmacol; 1994 Nov; 46(5):909-14. PubMed ID: 7969079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a clonal isolate of an oxaliplatin resistant ovarian carcinoma cell line A2780/C10.
    Hector S; Nava ME; Clark K; Murphy M; Pendyala L
    Cancer Lett; 2007 Jan; 245(1-2):195-204. PubMed ID: 16516375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of cyanohydroxybutene on glutathione synthesis in liver and pancreas of male rats.
    Davis MA; Wallig MA; Eaton D; Borroz KI; Jeffery EH
    Toxicol Appl Pharmacol; 1993 Dec; 123(2):257-64. PubMed ID: 7902618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in gamma-glutamylcysteine synthetase activity and steady-state messenger RNA levels in melphalan-resistant DU-145 human prostate carcinoma cells expressing elevated glutathione levels.
    Bailey HH; Gipp JJ; Ripple M; Wilding G; Mulcahy RT
    Cancer Res; 1992 Sep; 52(18):5115-8. PubMed ID: 1355406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of pulmonary gamma-glutamylcysteine synthetase heavy subunit in rats exposed to cadmium aerosols.
    Shukla GS; Chiu J; Hart BA
    Toxicol Appl Pharmacol; 2000 Mar; 163(3):249-59. PubMed ID: 10702364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro studies on the mechanisms of oxaliplatin resistance.
    Hector S; Bolanowska-Higdon W; Zdanowicz J; Hitt S; Pendyala L
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):398-406. PubMed ID: 11761458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. gamma-Glutamyl transpeptidase (gamma-GT) and maintenance of thiol pools in tumor cells resistant to alkylating agents.
    Ahmad S; Okine L; Wood R; Aljian J; Vistica DT
    J Cell Physiol; 1987 May; 131(2):240-6. PubMed ID: 2884224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts.
    Goddard P; Valenti M; Kelland LR
    Anticancer Res; 1994; 14(3A):1065-70. PubMed ID: 8074451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.
    Stordal BK; Davey MW; Davey RA
    Cancer Chemother Pharmacol; 2006 Aug; 58(2):256-65. PubMed ID: 16283310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.